PRGO (Perrigo) Rega marang bathi mangsa ngarep
Margin risks for Perrigo Company plc (PRGO) are driven by fierce competition in the private label segment and logistical disruptions. The change in the company's forward P/E multiple visualizes these factors, where the parameter value equals 7.20. Business resilience is supported by diversification into hygiene products and baby food. Management's current focus on asset optimization facilitates a long-term recovery in profitability.
Ringkesan rincian data analitis Perrigo Corp (PRGO)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Perrigo Company plc|PRGO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Perrigo Company plc|PRGO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Perrigo Company PLC|PRGO - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Perrigo|Likuiditas cepet perrigo.com
- rincian asil keuangan lan kelipatan valuasi:
PRGO - Bathi pungkasan|Bathi sing dikarepake Perrigo Company plc|PRGO - Nilai perusahaan marang bathi resik|Pangali Forward P/E Perrigo Company|PRGO - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Perrigo Company PLC|PRGO - Bathi operasional sadurunge potongan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Perrigo|PRGO - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan perrigo.com|PRGO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Perrigo Company plc
Pambiji fundamental:PRGO Perrigo
To minimize long-term capital risks, it is essential to avoid overvalued assets where an inflated multiple foreshadows a correction. By analyzing the company's consensus P/E forecast, an investor compares the current share price with expected earnings, which for the OTC market leader Perrigo Company plc (PRGO) reflects the efficiency of generic scaling and margin stability across global distribution, ultimately determining the business's investment attractiveness.
Analisis pesaing Perrigo Company plc
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|ALVO: Pangali Forward P/E|Liquidia Corp - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos Genomics) - Pangali Forward P/E|Rasio prakiraan rega marang bathi ANI Pharmaceuticals Corp ANIP|Rega marang bathi mangsa ngarep MannKind Corporation (MNKD)|AMPH (amphastar.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|SPRY (ARS Pharmaceuticals Inc) - Rasio rega marang bathi sing dikarepake|Theravance - Pangali Forward P/E|Rasio prakiraan rega marang bathi Aquestive Corp|scpharmaceuticals.com (SCPH) - Rega marang bathi mangsa ngarep|Tectonic Therapeutic - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Tonix Pharmaceuticals Holding Corp.|SXTC: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E EPRX|Kapitalisasi marang proyeksi bathi BioHarvest Sciences Inc|Pangali Forward P/E EXOZ (eXoZymes Inc)|Pangali forward rega marang bathi Oramed|ENTX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - Prakiraan rega marang bathi|Cumberland Corp - Pangali mangsa ngarep rega marang bathi|QNTM (Quantum BioPharma Ltd) - Pangali Forward P/E|Prakiraan rega marang bathi fibrogen.com (FGEN)|Rega marang bathi mangsa ngarep Telomir Pharmaceuticals, Inc. (TELO)|RANI - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Synergy CHC SNYR|RLYB - Prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake PULM|PTHL: Pangali Forward P/E|Aptorum Group (APM) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Lyra Therapeutics, Inc|Rasio rega marang bathi mangsa ngarep IBO (Impact BioMedical, Inc.)|Prakiraan rega marang bathi TNFA (TNF Pharmaceuticals)|YCBD - Rasio prakiraan rega marang bathi|PainReform - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CYTO|LIPO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake OPTN|Pieris Pharmaceuticals (PIRS) - Rega marang bathi mangsa ngarep|PROC (procapsgroup.com) - Rega marang bathi mangsa ngarep|PTPI (Petros Pharmaceuticals, Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Qilian International Holding Group (QLI)|Rega marang bathi mangsa ngarep ACELYRIN, Inc. (SLRN)|TFFP: Rasio rega marang bathi sing dikarepake
